English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/124691
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Monomeric C-reactive protein - A key molecule driving development of Alzheimer's disease associated with brain ischaemia?

AutorSlevin, Mark; Sarroca, Sara ; Font, M.ª Angels; Sanfeliu, Coral ; Revilla, Susana ; Badimón, Lina; Krupinski, Jerzy
Fecha de publicación3-sep-2015
EditorNature Publishing Group
CitaciónScientific Reports 5: 13281 (2015)
ResumenAlzheimer's disease (AD) increases dramatically in patients with ischaemic stroke. Monomeric C-reactive protein (mCRP) appears in the ECM of ischaemic tissue after stroke, associating with microvasculature, neurons and AD-plaques, Aβ, also, being able to dissociate native-CRP into inflammatory, mCRP in vivo. Here, mCRP injected into the hippocampal region of mice was retained within the retrosplenial tract of the dorsal 3rd ventrical and surrounding major vessels. Mice developed behavioural/cognitive deficits within 1 month, concomitant with mCRP staining within abnormal looking neurons expressing p-tau and in beta-amyloid 1-42-plaque positive regions. mCRP co-localised with CD105 in microvessels suggesting angiogenesis. Phospho-arrays/Western blotting identified signalling activation in endothelial cells and neurons through p-IRS-1, p-Tau and p-ERK1/2-which was blocked following pre-incubation with mCRP-antibody. mCRP increased vascular monolayer permeability and gap junctions, increased NCAM expression and produced haemorrhagic angiogenesis in mouse matrigel implants. mCRP induced tau244-372 aggregation and assembly in vitro. IHC study of human AD/stroke patients revealed co-localization of mCRP with Aβ plaques, tau-like fibrils and IRS-1/P-Tau positive neurons and high mCRP-levels spreading from infarcted core regions matched reduced expression of Aβ/Tau. mCRP may be responsible for promoting dementia after ischaemia and mCRP clearance could inform therapeutic avenues to reduce the risk of future dementia.
DescripciónM. Slevin et al.
Versión del editorhttp://dx.doi.org/10.1038/srep13281
Identificadoresdoi: 10.1038/srep13281
issn: 2045-2322
Aparece en las colecciones: (IIBB) Artículos
(CIC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Slevin-Scientific-Reports-2015-13281.pdf1,83 MBAdobe PDFVista previa
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.